Most Recent CDC Data Show 34,725 Deaths Reported Following COVID Vaccines

According to data from the Vaccine Adverse Event Reporting System (VAERS) released Friday, 1,533,182 adverse events following COVID-19 vaccines were reported between Dec. 14, 2020, and March 10, 2023. This includes 285,196 reports of serious injuries and 34,725 deaths.

Of the 34,725 reported deaths, 21,733 cases are attributed to Pfizer, 9,770 to Moderna, 2,964 to Johnson & Johnson, and 18 to Novavax. Of the reported deaths, 9% occurred within 24 hours of vaccination, and 13% occurred within 48 hours.

VAERS is a voluntary reporting system co-managed by the FDA and CDC designed to detect vaccine safety signals. It is considered an excellent, robust reporting system by vaccine makers (Pfizer) when they want to get out of having to track more detailed data on adverse events, but deeply flawed when it reveals safety signals the government and pharmaceutical companies want to ignore.

Excluding “foreign reports” to VAERS, 943,912 adverse events, including 17,114 deaths and 102,050 serious injuries, were reported in the U.S. between Dec. 14, 2020, and March 10, 2023.

Foreign reports are reports from foreign subsidiaries sent to U.S. vaccine manufacturers. Under FDA regulations, if a manufacturer is notified of a foreign case report describing an event that is serious and does not appear on the product’s labeling, the manufacturer must submit the report to VAERS.

As of March 8, 672 million COVID-19 vaccine doses were administered in the U.S., including 401 million doses of Pfizer, 252 million doses of Moderna, 19 million doses of Johnson & Johnson, and 82,000 doses of Novavax.

As of March 15, 54.2 million people received an experimental bivalent booster dose targeting the no-longer-existing Wuhan strain and obsolete BA.4/BA.5 omicron subvariants.

Since the rollout of bivalent boosters in September 2022 and March 10, there have been 24,641 adverse events reported to VAERS, with 40% attributed to Moderna’s booster and 60% attributed to Pfizer/BioNTech. The data included 221 deaths, 1,853 serious injuries, and 73 reports of myocarditis and pericarditis (heart inflammation).

The CDC’s myocarditis numbers are grossly underestimated, as the agency uses a narrowed case definition of myocarditis.

To meet the case definition of myocarditis, people must have had “symptoms such as chest pain, shortness of breath and feelings of having a fast-beating, fluttering or pounding heart, and medical tests to support the diagnosis of myocarditis and rule out other causes.”

This allows the CDC to exclude cases of cardiac arrest, ischemic strokes, and deaths due to heart problems that occur before one has the chance to go to the hospital, obtain a diagnosis, or “dies suddenly.”

The death of Joseph Keating is a prime example of a myocarditis case resulting in death that is excluded from CDC data.

The CDC website does not state what happens to these cases, but there is no indication they are tracked or included in the CDC’s myocarditis numbers.

Using MedAlerts, there were 5,950 adverse events, including 253 cases rated as serious and 13 reported deaths. Using the VAERS Aware dashboard, which locates reports the CDC excludes information from and/or miscategorizes to reduce deaths and certain adverse events, there were 29 reported deaths in children 6 months to age 5.

Here’s a list of the VAERS I.D. numbers for cross-reference:

Here’s a report of a little boy who died within ten days of receiving his six-month CDC-recommended shots. Do you think the CDC investigated this case and issued a recall? No.

According to MedAlerts, there were also 5 reports of myocarditis and pericarditis, 35 reports of blood clotting disorders, and 59 reports of seizures.

According to MedAlerts, there were 17,093 adverse events reported in the 5 to 11-year age group attributed to COVID vaccines, including 829 rated as serious and 34 reported deaths. The VAERS Aware dashboard picked up an additional 5 reports in this age group.

MedAlert shows 48 reports of myocarditis and pericarditis, 76 reports of blood clotting disorders, and 193 reports of seizures reported in this age group.

According to MedAlerts, there have been 41,527 adverse events, including 4,646 rated as serious and 139 reported deaths. VAERS Aware picked up 82 additional deaths reported in this age group.

Including reports in children up to age 18, VAERS Aware picked up an additional 138 reports—meaning there were 277 reported deaths in the 12- to 18-year age group.

There were 276 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment, or resulted in death, 1,352 reports of myocarditis and pericarditis, 312 reports of blood clotting disorders and 31 cases of postural orthostatic tachycardia syndrome (POTS).

• 16% of deaths were related to cardiac disorders.
• 53% of those who died were male, and 41% were female. The remaining death reports do not list the gender of the deceased.
• The average age of death was 72.
• As of Feb. 17, 9,035 pregnant women reported adverse events related to COVID-19 vaccines, including 5,231 reports of miscarriage or premature birth.
• Of the 17,139 cases of Bell’s palsy reported, 73% were attributed to Pfizer vaccinations, 22% to Moderna, and 5% to J&J.
• 3,258 reports of Guillain-Barré syndrome.
• 10,400 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
• 8,488 reports of myocardial infarction and cardiac arrest.
• 46,131 reports of blood-clotting disorders. Of those, 31,677 reports were attributed to Pfizer, 10,436 reports to Moderna, and 3,943 reports to Johnson & Johnson.
• 25,487 cases of myocarditis and pericarditis, with 19,349 cases attributed to Pfizer, 5,636 cases to Moderna, and 442 to Johnson & Johnson.
• 79 cases of Creutzfeldt-Jakob disease, with 65 cases attributed to Pfizer, 12 to Moderna, and 2 to J&J.
• 706 cases of POTS, with 523 cases attributed to Pfizer, 155 cases to Moderna, and 27 cases to Johnson & Johnson.

Although healthcare providers are required by law to report vaccine adverse events to VAERS, research shows very few do. It is essential that anyone who experiences an adverse event report their own injury.